Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 21778 [2012-8660]
Download as PDF
<![CDATA[
21778
Federal Register / Vol. 77, No. 70 / Wednesday, April 11, 2012 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
Board of Scientific Counselors, Office
of Infectious Diseases (BSC, OID)
Dated: April 5, 2012.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
The meeting announced below
concerns Development and Testing of a
Clinic-Based Intervention to Increase
Dual Protection against Unintended
Pregnancy and STDs among High Risk
Female Teens, FOA DP12–001, initial
review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Dates: Time and Date:
11 a.m.–5 p.m., May 8, 2012 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Development and Testing of a
Clinic-Based Intervention to Increase Dual
Protection against Unintended Pregnancy
and STDs among High Risk Female Teens,
FOA DP12–001, initial review.’’
Contact Person For More Information: M.
Chris Langub, Ph.D., Scientific Review
Officer, CDC, 4770 Buford Highway NE.,
Mailstop F–46, Atlanta, Georgia 30341,
Telephone: (770) 488–3585.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: April 1, 2012.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2012–8660 Filed 4–10–12; 8:45 am]
wreier-aviles on DSK5TPTVN1PROD with NOTICES
BILLING CODE 4163–18–P
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
TIME AND DATE: 8 a.m.–2:50 p.m., May 2,
2012.
PLACE: CDC, Global Communications
Center, 1600 Clifton Road NE., Building
19, Auditorium B3, Atlanta, Georgia
30333.
STATUS: Open to the public, limited only
by the space available.
PURPOSE: The BSC, OID, provides
advice and guidance to the Secretary,
Department of Health and Human
Services; the Director, CDC; the
Director, OID; and the Directors of the
National Center for Immunization and
Respiratory Diseases, the National
Center for Emerging and Zoonotic
Infectious Diseases, and the National
Center for HIV/AIDS, Viral Hepatitis,
STD, and TB Prevention, CDC, in the
following areas: strategies, goals, and
priorities for programs; research within
the national centers; and overall
strategic direction and focus of OID and
the national centers.
MATTERS TO BE CONSIDERED: The meeting
will include reports from the BSC OID
working groups, brief updates from the
infectious disease national centers, and
focused discussions on CDC’s safe water
activities, immunization infrastructure,
and sexually transmitted diseases.
Agenda items are subject to change as
priorities dictate.
CONTACT PERSON FOR MORE INFORMATION:
Robin Moseley, M.A.T., Designated
Federal Officer, OID, CDC, 1600 Clifton
Road NE., Mailstop D10, Atlanta,
Georgia 30333, Telephone: (404) 639–
4461.
The Director, Management Analysis
and Services Office has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
[FR Doc. 2012–8682 Filed 4–10–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review;
Comment Request
Title: Uniform Project Description
(UPD) Program Narrative Format for
Discretionary Grant Application Forms.
OMB No.: 0970–0139
Description: The proposed
information collection would extend the
Administration for Children and
Families’ (ACF) Uniform Project
Description (UPD). The UPD provides a
uniform grant application format for
applicants to submit project information
in response to ACF discretionary
funding opportunity announcements.
ACF uses this information, along with
other OMB-approved information
collections (Standard Forms), to
evaluate and rank applications. Use of
the UPD helps to protect the integrity of
ACF’s award selection process. All ACF
discretionary grant programs are
required to use this application format.
The application consists of general
information and instructions; the
Standard Form 424 series, which
requests basic information, budget
information, and assurances; the Project
Description that requests the applicant
to describe how program objectives will
be achieved; and other assurances and
certifications. Guidance for the content
of information requested in the Project
Description is found in OMB Circular
A–102; 2 CFR, Part 215; 2 CFR, Part 225;
2 CFR, Part 230; 45 CFR, Part 74; and
45 CFR, Part 92.
Respondents: Applicants to ACF
Discretionary Funding Opportunity
Announcements.
ANNUAL BURDEN ESTIMATES
Instrument
Number of
respondents
Number of
responses per
respondent
Average
burden hours
per response
Total
burden hours
ACF Uniform Project Description .....................................................................
5,500
1
60
330,000
VerDate Mar<15>2010
15:14 Apr 10, 2012
Jkt 226001
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
E:\FR\FM\11APN1.SGM
11APN1
]]>Agencies
[Federal Register Volume 77, Number 70 (Wednesday, April 11, 2012)]
[Notices]
[Page 21778]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-8660]
[[Page 21778]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below concerns Development and Testing of a
Clinic-Based Intervention to Increase Dual Protection against
Unintended Pregnancy and STDs among High Risk Female Teens, FOA DP12-
001, initial review.
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting:
Dates: Time and Date:
11 a.m.-5 p.m., May 8, 2012 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance
with provisions set forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters To Be Discussed: The meeting will include the initial
review, discussion, and evaluation of applications received in
response to ``Development and Testing of a Clinic-Based Intervention
to Increase Dual Protection against Unintended Pregnancy and STDs
among High Risk Female Teens, FOA DP12-001, initial review.''
Contact Person For More Information: M. Chris Langub, Ph.D.,
Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F-
46, Atlanta, Georgia 30341, Telephone: (770) 488-3585.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Dated: April 1, 2012.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2012-8660 Filed 4-10-12; 8:45 am]
BILLING CODE 4163-18-P
